# OnCo record paper-ptld-1-risk-stratified-sequential-treatment-trappe-jco-2017 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-ptld-1-risk-stratified-sequential-treatment-trappe-jco-2017/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-ptld-1-risk-stratified-sequential-treatment-trappe-jco-2017" ;
  schema:name "PTLD-1: response to rituximab induction as a predictive marker allowing stratification into rituximab or R-CHOP consolidation in B-cell post-transplant lymphoproliferative disorder"@en ;
  schema:description "In lymphoma arising after an organ transplant, starting with rituximab alone and then choosing between more rituximab and chemotherapy by response gave complete remission in seven of ten patients and a median survival of more than six years."@en ;
  schema:url <https://onco.cc/key-papers/paper-ptld-1-risk-stratified-sequential-treatment-trappe-jco-2017/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.2016.69.3564>, <https://pubmed.ncbi.nlm.nih.gov/27992268/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.2016.69.3564> ;
  schema:datePublished "2017"^^xsd:gYear ;
  schema:author "Trappe RU, Dierickx D, Zimmermann H, et al." ;
  onco:cancers <https://onco.cc/cancers/post-transplant-lymphoproliferative-disorder/> ;
  onco:drugs <https://onco.cc/drugs/rituximab/> ;
  onco:trials <https://onco.cc/trials/ptld-1/> ;
  onco:journals <https://onco.cc/journals/jco/> .